Tag: Reducer
German NUB Status 1 designation for Neovasc Reducer renewed
Neovasc has announced that the Institut für das Entgeltsystem im Krankenhaus (InEk)— the German Inst...
Safety and efficacy results of REDUCE study published in International Journal of Cardiology
The manuscript “Safety and efficacy of the Reducer: A multicentre clinical registry—REDUCE study...
Neovasc receive approval to initiate COSIRA-II IDE clinical trial
Neovasc has received approval of the US FDA to initiate the COSIRA-II IDE clinical trial. The trial...
